Viral-associated GN hepatitis B and other viral infections

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 9, 2017, Pages 1529-1533

  Kupin, Warren L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ASPARTIC ACID; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; METHIONINE; RITUXIMAB; TELBIVUDINE; TENOFOVIR; TYROSINE; VIRUS ANTIGEN; ANTIVIRUS AGENT;

ACUTE KIDNEY TUBULE NECROSIS; ANTIVIRAL THERAPY; ARTICLE; CRYOGLOBULINEMIA; CYTOMEGALOVIRUS INFECTION; DENGUE HEMORRHAGIC FEVER; DENGUE SHOCK SYNDROME; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HYPOVOLEMIA; IMMUNE COMPLEX DISEASE; KIDNEY INJURY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PLASMAPHERESIS; POLYARTERITIS NODOSA; RHABDOMYOLYSIS; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS ASSOCIATED GLOMERULONEPHRITIS; VIRUS CARRIER; VIRUS INFECTION; ANIMAL; DRUG EFFECT; GLOMERULUS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; PREVALENCE; PROGNOSIS; RISK FACTOR; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; KIDNEY GLOMERULUS; PREVALENCE; PROGNOSIS; RISK FACTORS; VIRUS REPLICATION;

EID: 85029594102     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09180816     Document Type: Article

References (43)

1. Nast CC: Infection-related glomerulonephritis: changing demographics andoutcomes. AdvChronic Kidney Dis 19: 68–75, 2012
2. Kanjanabuch T, Kittikowit W, Eiam-Ong S: An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol 5: 259–269, 2009
3. Nadasdy T, Hebert LA: Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol 31: 369–375, 2011
4. Glassock RJ, Alvarado A, Prosek J, Hebert C, Parikh S, Satoskar A, Nadasdy T, Forman J, Rovin B, Hebert LA: Staphylococcusrelated glomerulonephritis and poststreptococcal glomerulonephritis: why defining “post” is important in understanding and treating infection-related glomerulonephritis. Am J Kidney Dis 65: 826–832, 2015
5. Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N: Hepatitis B virus burden in developing countries. World J Gastroenterol 21: 11941–11953, 2015
6. Gupta A, Quigg RJ: Glomerular Diseases Associated With Hepatitis B and C. Adv Chronic Kidney Dis 22: 343–351, 2015
7. Basnayake SK, Easterbrook PJ: Wide variation in estimates of global prevalence and burden and death estimates from chronic HBV, HCVand coinfectionwith HIVin literature. J ViralHepat 23: 545–559, 2016
8. Li P, Wei RB, Tang L, Wu J, Zhang XG, Chen XM: Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy. Clin Nephrol 78: 456–464, 2012
9. Bhimma R, Coovadia HM: Hepatitis B virus-associated nephropathy. Am J Nephrol 24: 198–211, 2004
10. Hui D, Yan X, Wei J, Ruixia M, Guangju G: Significance of mutations in hepatitis B virus X gene for the pathogenesis of HB-associated glomerulonephritis. Acta Virol 58: 278–281, 2014
11. Obrisca B, Ismail G, Jurubita R, Baston C, Andronesi A, Mircescu G: Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy. Biomed Res Int 2015: 249740, 2015
12. Beck LH Jr, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11–21, 2009
13. Xie Q, Li Y, Xue J, Xiong Z, Wang L, Sun Z, Ren Y, Zhu X, Hao CM: Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am J Nephrol 41: 345–353, 2015
14. Lee CJ, Suh KS, Kim KH, Chang YK, Na KR, Lee KW: The clinicopathologic significance of endothelial tubuloreticular inclusions in glomerular diseases. Ultrastruct Pathol 37: 386–394, 2013
15. Ozdamar SO, Gucer S, Tinaztepe K: Hepatitis-B virus associated nephropathies: a clinicopathological study in 14children. Pediatr Nephrol 18: 23–8, 2003
16. Hsu HC, Wu CY, Lin CY, Lin GJ, Chen CH, Huang FY: Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan. Kidney Int 36: 1103–1107, 1989
17. Venkataseshan VS, Lieberman K, Kim DU, Thung SN, Dikman S, D’Agati V, Susin M, Valderrama E, Gauthier B, Prakash A, Churg J: Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course. Medicine (Baltimore) 69: 200–216, 1990
18. Li SJ, Xu ST, Chen HP, Zhang MC, Xu F, Cheng SQ, Liu ZH: Clinical and Morphologic Spectrum of Renal Involvement in Patients with HBV-Associated Cryoglobulinemia [published online ahead of print April 7, 2016]. Nephrology (Carlton) doi: 10.1111/nep.12795, 2016
19. KDIGO Glomerulonephritis Work Group: Kidney Disease: Improving Global Outcomes. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2: 200–208, 2012
20. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL: Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24: 714–717, 1996
21. Elewa U, Sandri AM, Kim WR, Fervenza FC: Treatment of hepatitis B virus-associated nephropathy. Nephron Clin Pract 119: c41–c49, discussion c49, 2011
22. Zheng XY, Wei RB, Tang L, Li P, Zheng XD: Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol 18: 821–832, 2012
23. Liao MT, Chang MH, Lin FG, Tsai IJ, Chang YW, Tsau YK: Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 128: e600–e604, 2011
24. Sharma A, Sharma K: Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis. J Clin Exp Hepatol 3: 204–212, 2013
25. Sun IO, Hong YA, Park HS, Choi SR, Chung BH, Park CW, Yang CW, Kim YS, Choi BS: Clinical characteristics and treatment of patients withIgAnephropathyandhepatitisBsurface antigen. Ren Fail 35: 446–451, 2013
26. Zhou TB, Jiang ZP: Is there an association of hepatitis B virus infectionwith minimal change disease of nephrotic syndrome? A clinical observational report. Ren Fail 37: 459–461, 2015
27. Mallhi TH, Sarriff A, Adnan AS, Khan YH, Hamzah AA, Jummaat F, Khan AH: Dengue-induced Acute Kidney Injury (DAKI): A Neglected and Fatal Complication of Dengue Viral Infection–A Systematic Review. J Coll Physicians Surg Pak 25: 828–834, 2015
28. Lizarraga KJ, Nayer A: Dengue-associated kidney disease. J Nephropathol 3: 57–62, 2014
29. Kruger DH, Figueiredo LT, Song JW, Klempa B: Hantaviruses–globally emerging pathogens. J Clin Virol 64: 128–136, 2015
30. Murray KO, Fischer RS, Chavarria D, Duttmann C, Garcia MN, Gorchakov R, Hotez PJ, Jiron W, Leibler JH, Lopez JE, Mandayam S, Marin A, Sheleby J: Mesoamerican nephropathy: a neglected tropical disease with an infectious etiology? Microbes Infect 17: 671–675, 2015
31. Boehlke C, Hartleben B, Huber TB, Hopfer H, Walz G, Neumann-Haefelin E: Hantavirus infection with severe proteinuria and podocyte foot-process effacement. AmJ KidneyDis 64: 452–456, 2014
32. Jiang H, Du H, Wang LM, Wang PZ, Bai XF: Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture. Front Cell Infect Microbiol 6: 1, 2016
33. Chandra P, Kopp JB: Viruses and collapsing glomerulopathy: a brief critical review. Clin Kidney J 6: 1–5, 2013
34. di Belgiojoso GB, Ferrario F, Landriani N: Virus-related glomerular diseases: histological andclinical aspects. JNephrol 15: 469–479, 2002
35. Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB: Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 35: 1166–1174, 2000
36. Schwimmer JA, Markowitz GS, Valeri A, Appel GB: Collapsing glomerulopathy. Semin Nephrol 23: 209–218, 2003
37. Beneck D, Greco MA, Feiner HD: Glomerulonephritis in congenital cytomegalic inclusion disease. Hum Pathol 17: 1054–1059, 1986
38. Dettmar AK, Oh J: Infection-Related Focal Segmental Glomerulosclerosis in Children. BioMed Res Int 2016: 7351964, 2016
39. Araya CE, González-Peralta RP, Skoda-Smith S, Dharnidharka VR: Systemic Epstein-Barr virus infection associated with membranous nephropathy in children. Clin Nephrol 65: 160–164, 2006
40. Joshi A, Arora A, Cimbaluk D, Dunea G, Hart P: Acute Epstein-Barr virus infection-associated collapsing glomerulopathy. Clin Kidney J 5: 320–322, 2012
41. Divers J, Núñez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI: J Cpolyomavirus interacts withAPOL1 in AfricanAmericanswith nondiabetic nephropathy. Kidney Int 84: 1207–1213, 2013
42. Mac Donald NE, Wolfish N, McLaine P, Phipps P, Rossier E: Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Pediatr 108: 378–382, 1986
43. Wenderfer SE: Viral-associated glomerulopathies in children. Pediatr Nephrol 30: 1929–1938, 2015